Premium
Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions
Author(s) -
Bracchi Robert C.,
Tseliou Foteini,
Copeland Lauren,
Routledge Philip A.,
Thomas Alison,
Woods Fiona,
Adams Alana,
Walker Jenna,
Jadeja Mitul,
Atkinson Mark D.,
AshfieldWatt Pauline
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14726
Subject(s) - drug reaction , medicine , adverse drug reaction , public health , adverse effect , family medicine , pharmacovigilance , drug , nursing , pharmacology
We used the HealthWise Wales (HWW) platform to explore public knowledge about the UK Yellow Card scheme (YCS), the spontaneous reporting scheme for suspected adverse drug reactions (ADRs) and whether a short information video could improve awareness. Members of the public in Wales ( n = 1606) completed a questionnaire about the YCS, watched the information video and then completed a follow‐up questionnaire. Almost half (46.5%) of respondents said they had previously experienced an ADR (>90% of the ADRs involving prescribed medicines). Before the video, 18% of respondents knew how to report an ADR via the YCS and of these, 34% were from allied‐health professions. Immediately after watching it, 71% participants reported knowing how to report and 82% reported being confident to report. If this awareness were maintained, such an approach could contribute to improved reporting of suspected ADRs by the public.